| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962860 | Vaccine | 2016 | 10 Pages |
Abstract
These results implicate the use of functionally conserved regions of Pol in addition to the widely used Gag for T-cell vaccine design. Proportion of volunteers developing these effectors and their frequency in circulating PBMC are separate issues, which can be addressed, if needed, by more efficient vector and regimen delivery of conserved immunogens.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Tina Ahmed, Nicola J. Borthwick, Jill Gilmour, Peter Hayes, Lucy Dorrell, TomáÅ¡ Hanke,